Q1 2018 Peregrine Pharmaceuticals Inc Earnings Call

11/9/2017 16:30

Conference Call Peregrine Pharmaceuticals Inc

Peregrine Pharmaceuticals Inc Conference call or earnings call will be held on Sep 11, 2017
During the earnings conference call’s session, Peregrine Pharmaceuticals Inc will provide updated information and financial performance report status.
In order to join the earning call, dial the conference’s bridge and key in the PIN code. Contact Peregrine Pharmaceuticals Inc for this information
More and more companies choose to conduct their earnings calls through conference calls and online meetings and it’s important to keep up to date with all relevant information.
Need a conference calls service solution? Try QCONF conferencing today, Sign up now and get 5 free conference calls (no credit card required)
Is this is your first earnings call? Check out Nasdaq guide for how to read an earnings report?
We are a biopharmaceutical company committed to improving the lives of patients by delivering high quality pharmaceutical products through our contract manufacturing business and through advancing and licensing our novel, development-stage immunotherapy products. Avid Bioservices, Inc. ("Avid") is a contract development and manufacturing organization ("CDMO") and a wholly-owned subsidiary of Peregrine Pharmaceuticals, Inc. ("Peregrine"). In June 2016, we announced a new corporate strategy to achieve profitability within two (2) years (during the quarter ending July 31, 2018), and at the same time, refocus our internal drug development efforts on small, early stage clinical trials designed to attract partnering interest in our investigational products.    
Read more Conference Call

Peregrine Pharmaceuticals Inc (PPHM)

14282 Franklin Avenue, Tustin California 92780, United States